Insider Stock Trading History of Gadicke Ansbert


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Gadicke Ansbert since year 2005. The trader's CIK number is 1134655. At the time of this reporting, Gadicke Ansbert is the 10% Owner of Aratana Therapeutics, Inc. . (stock ticker symbol PETX). See this page for all insider trading activities at Aratana Therapeutics, Inc. .

Note that in the past GADICKE ANSBERT also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Gadicke Ansbert since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2014-03-07 PETX Aratana Therapeutics, Inc. Sale 26,713 20.16 538,534
2014-02-10 EPZM Epizyme, Inc. Sale 466,666 29.25 13,649,980
2013-03-11 PCRX Pacira Pharmaceuticals, Inc. Sale 500,000 27.86 13,930,000
2012-07-06 SOMX Somaxon Pharmaceuticals, Inc. Sale 671,217 .29 195,324
2012-07-09 SOMX Somaxon Pharmaceuticals, Inc. Sale 1,624,574 .31 498,744
2012-07-02 SOMX Somaxon Pharmaceuticals, Inc. Sale 80,348 .29 23,300
2012-07-03 SOMX Somaxon Pharmaceuticals, Inc. Sale 98,210 .29 28,480
2012-06-28 SOMX Somaxon Pharmaceuticals, Inc. Sale 19,500 .29 5,655
2012-06-19 SOMX Somaxon Pharmaceuticals, Inc. Sale 12,000 .29 3,479
2012-06-15 SOMX Somaxon Pharmaceuticals, Inc. Sale 1,450 .29 420
2012-06-05 SOMX Somaxon Pharmaceuticals, Inc. Sale 29,555 .29 8,570
2012-06-06 SOMX Somaxon Pharmaceuticals, Inc. Sale 8,400 .29 2,436
2012-02-01 VSTM Verastem, Inc. Buy 100,000 10.00 1,000,000
2011-11-21 PCRX Pacira Pharmaceuticals, Inc. Buy 461,538 6.50 2,999,997
2012-02-08 PCRX Pacira Pharmaceuticals, Inc. Buy 535,714 7.00 3,749,998
2008-06-19 VRUS Pharmasset Inc Sale 155,800 19.93 3,105,717
2008-06-17 VRUS Pharmasset Inc Sale 101,900 20.18 2,056,545
2008-06-16 VRUS Pharmasset Inc Sale 281,149 20.31 5,709,855
2008-06-13 VRUS Pharmasset Inc Sale 1,321 19.00 25,099
2008-06-16 VRUS Pharmasset Inc Sale 18,979 19.19 364,169
2008-06-10 VRUS Pharmasset Inc Sale 5,175 19.06 98,625
2008-06-05 VRUS Pharmasset Inc Sale 10,083 19.15 193,049
2008-02-07 VRUS Pharmasset Inc Sale 36,664 23.02 844,005
2008-02-08 VRUS Pharmasset Inc Sale 27,925 21.36 596,478
2008-02-04 VRUS Pharmasset Inc Sale 27,300 23.86 651,378
2007-05-02 VRUS Pharmasset Inc Buy 277,777 9.00 2,499,993
2006-10-23 OMRI Omrix Biopharmaceuticals, Inc. Sale 14,225 19.95 283,788
2006-10-24 OMRI Omrix Biopharmaceuticals, Inc. Sale 15,095 19.76 298,216

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Gadicke Ansbert (10% Owner of Aratana Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.